1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBLOODSAFE Program: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries in Sub-Saharan Africa is sponsored by National Heart, Lung, and Blood Institute (NHLBI), NIH. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa | NHLBI, NIH Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa Q1.
What countries are part of Sub-Saharan Africa (SSA)? A1. Please refer to Sub-Saharan African Region Information provided by the Fogarty International Center of NIH .
Q2. Is a component of a US institution in a low-income or lower-middle income country in Sub-Saharan Africa eligible to apply? A2.
Yes, if the component of a US institution in a low-income or lower-middle income country in Sub-Saharan Africa is able to submit grant applications to and receive awards from NIH directly without going through the US institution. This also applies to a component of any other country’s institution in a low-income or lower-middle income country in Sub-Saharan Africa. Q3.
Can an investigator from a country outside of Sub-Saharan Africa or from a country that is not low-income or lower-middle income serve as a co-PI? A3. Yes, as long as the primary PI is from an institution in a low-income or lower-middle income country of Sub-Saharan Africa, that is, the institution in a low-income or lower-middle income country of Sub-Saharan Africa will be the grantee institution.
Investigators from a country outside of Sub-Saharan Africa or from a country that is not low-income or lower-middle income can also serve as co-investigators or consultants. Q4. The FOA indicated only one award per country.
What will happen if two different PIs from the same eligible country and their respective teams of investigators submitted two different applications? A4. The idea of having only one award per country is to have as many countries represented in the final consortium as possible and also to discourage one primary PI from submitting more than one application.
If two different (primary) PIs from the same eligible country submitted two different applications, both applications will be evaluated by the peer review panel with consideration of an award based on scientific merit.
According to the current listing, eligibility includes: Research teams in Sub-Saharan Africa. Universities, often in collaboration with U. S. institutions, are eligible for this type of research funding. Confirm the full requirements in the official notice before applying.
The current listing shows not specified (program supported by research grants UG3HL151595, UG3HL151599, UG3HL152189, and U24HL151541). Verify award ceilings, matching requirements, and allowable costs in the official notice.
BLOODSAFE Program: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries in Sub-Saharan Africa is funded by National Heart, Lung, and Blood Institute (NHLBI), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article